Enter inventor name

Average Co-Inventor Count = 3.6

ph-index = 32

Forward Citations = 5,224(Granted Patents)

Location History:

Providence, RI (US) (1989 - 1992)
Lutry, CA (1998)
Chemin de Plantaz, CH (1999 - 2000)
Barrington, RI (US) (1991 - 2001)
Lutry, CH (1998 - 2005)

Company Filing History:

Cytotherapeutics, Inc.

Pfizer Hospital Products Group, Inc.

Ecole Polytechnique Federale De Lausanne

patents

where one patent can have more than one assignee

Years Active: 1989-2005

Loading Chart...

Areas of Expertise:

Biocompatible Implants

Gene Therapy

Neurodegenerative Treatments

Bioartificial Matrices

Cell Encapsulation

Neural Signal Transmission

Neuroinhibitory Compounds

Insulin Delivery

Nerve Guidance Channels

Pharmaceutical Microencapsulation

Therapeutic Delivery Systems

Extracellular Matrix

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6960351 - Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products (2005-11-01),

2. 6322804 - Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products (2001-11-27),

3. 6179826 - Implantable therapy systems and methods (2001-01-30),

4. 6156572 - Bioartificial extracellular matrix containing hydrogel matrix (2000-12-05),

5. 6140089 - Chitosan core matrix containing cells encapsulated in a thermoplastic (2000-10-31),

6. 6083523 - Implantable biocompatable immunoisolatory vehicle for delivery of (2000-07-04),

7. 6080412 - Pharmaceutical microencapsulation (2000-06-27),

8. 6027721 - Device and method for encapsulated gene therapy (2000-02-22),

9. 5935849 - Methods and compositions of growth control for cells encapsulated within (1999-08-10),

10. 5874099 - Methods for making immunoisolatary implantable vehicles with a (1999-02-23),

11. 5871985 - Particulate non cross-linked chitosan core matrices for encapsulated (1999-02-16),

12. 5871767 - Methods for treatment or prevention of neurodegenerative conditions (1999-02-16),

13. 5871472 - Planting devices for the focal release of neuroinhibitory compounds (1999-02-16),

14. 5869077 - Methods for treating diabetes by delivering insulin from biocompatible (1999-02-09),

15. 5858747 - Control of cell growth in a bioartificial organ with extracellular (1999-01-12),

Title: Patrick Aebischer - Innovative Inventor from Lutry, CH

Introduction: Patrick Aebischer is a renowned inventor hailing from Lutry, Switzerland, known for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Patrick Aebischer holds several patents related to neurotechnology and regenerative medicine, focusing on novel treatments for neurological disorders and innovative medical devices.

Career Highlights: With a distinguished career spanning decades, Aebischer has served in key roles at prestigious research institutions and universities, leading pioneering projects that have pushed the boundaries of scientific discovery.

Collaborations: Throughout his career, Patrick Aebischer has collaborated with top researchers, scientists, and medical professionals worldwide, fostering a culture of innovation and knowledge exchange in the scientific community.

Conclusion: Patrick Aebischer's relentless pursuit of innovation and his commitment to improving healthcare through cutting-edge technologies have solidified his reputation as a visionary inventor in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com